Biogen will pay Carlsbad’s Ionis Pharmaceuticals $1 billion in cash as part of a 10-year collaboration around neurological drug development.
Citing regulatory changes, San Diego’s Tocagen licensed its immunotherapy for commercialization in China, earning the company $16 million upfront and potentially much more.
French diagnostics giant bioMérieux acquired San Diego-based Astute Medical in a $90 million cash deal announced earlier this month.
Sharp Grossmont Hospital has opened a new clinic, which looks to reduce patient volumes in the hospital’s emergency room, one of the busiest in San Diego County.
Biological Dynamics, a San Diego cancer diagnostics company, named Irwin Jacobs and Martin Wygod to its board, it was announced April 13.
The company said the pilot program will put up to 100 San Diego Fire-Rescue Department firefighters and 10 alternates through screening, including genome sequencing.
Tandem Diabetes Care reported a 42 percent year-over-year increase in preliminary quarter one sales, increasing the company’s stock.
San Diego-based Illumina, Inc. (Nasdaq: ILMN) and Loxo Oncology (Nasdaq: LOXO) in Stamford, Conn., announced on April 10, a global strategic partnership to develop and commercialize a multi-gene panel for broad tumor profiling.
The biotechnology company described the financing round as oversubscribed.
Acadia fell from over $21 per share to $16.50 as of market close April 9.
Clarify Medical's CEO was formerly head of Neothetics, which merged into San Diego company Evofem Biosciences after its experimental drug failed in the clinic.
BIOTECH: Partnership, Sales Boost Are Part of Positives
Tandem Diabetes Care believes the storm has passed.
Imagion Biosystems Ltd.,'s new home will be on Science Center Drive.
BIOTECH: Optum360’s System Covers All the Bases for Variety of Users
A San Diego offshoot is deploying artificial intelligence against a crushing administrative burden: electronic health records.